Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgeryâ€

Pre-treatment with levosimendan in patients undergoing surgical myocardial revascularization resulted in less myocardial injury, a reduction in tracheal intubation time, less requirement for inotropic support, and a shorter length of ICU stay.